Clinical Trials Browser

Phase 2 × Advanced Solid Tumors × osimertinib × Clear all

NCT06895928 2025-04-22

A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Advanced Solid Tumors